Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON34877Phase 4Active, not recruiting
Phase 4, randomised, open-label trial of remifentanil and pethidine in None, sponsored by Vrije University Medical Center. Primary endpoint: Pain during oocyte retrieval. Started Jun 2010; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON34877.